We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMBH icon
4276
First Mid Bancshares
FMBH
$1.38B
$12K ﹤0.01%
291
-51
-15% -$2.18K
FNLC icon
4277
First Bancorp
FNLC
$402M
$12K ﹤0.01%
381
-22
-5% -$668
FRD icon
4278
Friedman Industries
FRD
$331M
$12K ﹤0.01%
1,250
+1,150
+1,150% +$13.5K
GAN
4279
DELISTED
GAN Ltd
GAN
$12K ﹤0.01%
1,336
+39
+3% +$477
GNLN icon
4280
Greenlane Holdings
GNLN
$1.22M
0
GTBP icon
4281
GT Biopharma
GTBP
$10.7M
$12K ﹤0.01%
130
+16
+14% +$2.39K
HBNC icon
4282
Horizon Bancorp
HBNC
$1.06B
$12K ﹤0.01%
563
-2,147
-79% -$42.2K
HFFG icon
4283
HF Foods Group
HFFG
$99.2M
$12K ﹤0.01%
1,470
-724
-33% -$5.34K
HOFT icon
4284
Hooker Furnishings Corp
HOFT
$158M
$12K ﹤0.01%
503
-1,047
-68% -$26.3K
STRR
4285
Star Equity Holdings
STRR
$36.2M
$12K ﹤0.01%
+422
New +$9.58K
ICVT icon
4286
iShares Convertible Bond ETF
ICVT
$7.67B
$12K ﹤0.01%
+137
New +$13.3K
IMNM icon
4287
Immunome
IMNM
$3.09B
$12K ﹤0.01%
+926
New +$16.5K
IX icon
4288
ORIX
IX
$43.6B
$12K ﹤0.01%
+590
New +$11.7K
IXC icon
4289
iShares Global Energy ETF
IXC
$2.77B
$12K ﹤0.01%
+444
New +$12.6K
KOPN icon
4290
Kopin
KOPN
$1.02B
$12K ﹤0.01%
2,963
-26,100
-90% -$133K
KRO icon
4291
KRONOS Worldwide
KRO
$975M
$12K ﹤0.01%
810
+243
+43% +$3.39K
LFCR icon
4292
Lifecore Biomedical
LFCR
$179M
$12K ﹤0.01%
1,061
+14
+1% +$136
LFMD icon
4293
LifeMD
LFMD
$166M
$12K ﹤0.01%
2,983
+327
+12% +$1.55K
LPG icon
4294
Dorian LPG
LPG
$2.03B
$12K ﹤0.01%
931
-16,214
-95% -$205K
LRMR icon
4295
Larimar Therapeutics
LRMR
$453M
$12K ﹤0.01%
1,126
-4,717
-81% -$52.5K
LWAY icon
4296
Lifeway Foods
LWAY
$390M
$12K ﹤0.01%
2,428
+2,302
+1,827% +$12.3K
MAYS icon
4297
J.W. Mays
MAYS
$83.7M
$12K ﹤0.01%
297
-11
-4% -$409
MEC icon
4298
Mayville Engineering Co
MEC
$614M
$12K ﹤0.01%
821
-64
-7% -$1.05K
MFIC icon
4299
MidCap Financial Investment
MFIC
$803M
$12K ﹤0.01%
932
-5,498
-86% -$72.2K
MILN
4300
Global X Millennial Consumer ETF
MILN
$103M
$12K ﹤0.01%
290
+282
+3,525% +$12.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.